Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Oramed Initiates Second Phase 3 Oral Insulin Study

americanpharmaceuticalreviewMarch 30, 2021

Tag: Oramed , T2D , ORMD-0801 , ORA-D-013-2

PharmaSources Customer Service